Furthermore, this treatment induced a reduction of C16:0 ceramides plasma levels, resulting in improved glucose tolerance and insulin sensitivity, confirming the strict correlation between ceramide, obesity and insulin resistance again. This evidence concerns the gene INS and Insulin resistance.